Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma
NCT01219751Phase 2Unknown
- Sponsor
- Asan Medical Center
- Start
- Jun 2008
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in non-clear cell renal cell carcinoma (nccRCC), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
sunitinib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT01219751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01219751.